Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

1 results
12:00 AM, Sep 15, 2014  |  BC Week In Review | Company News  |  Sales & Marketing

Chugai sales and marketing update

Chugai launched Alecensa alectinib in Japan to treat unresectable, recurrent or advanced anaplastic lymphoma kinase (ALK)-positive …
Basel, Switzerland), which is the majority owner of Chugai, has rights to the compound elsewhere. Alecensa